Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf crawled date : 2022 - 10 - 26 save search
BioMarin Announces Third Quarter 2022 Year-over-Year Total Revenue Growth of 24% (31% Excluding KUVAN®)
Published: 2022-10-26 (Crawled : 20:00) - investors.biomarin.com
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
BMRN | $83.35 -8.61% 1.1M
|
Health Technology
|
| O: -2.68%
H: 0.0%
C: -4.35%
kuvan growth
The Global Medical Exoskeletons Market to Register Positive Growth at a Significant CAGR of 18.23% by 2027 | DelveInsight
Published: 2022-10-26 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
NVRO | $11.835 -5.4% 22K
|
Health Technology
|
| O: -1.43%
H: 0.0%
C: -4.66%
MDT | $79.69 -0.86% 400K
|
Health Technology
|
| O: 0.46%
H: 2.07%
C: 0.57%
JNJ | News | $147.46 -0.72% 820K
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
BSX | $73.22 0.43% 1.3M
|
Health Technology
|
| O: 1.6%
H: 1.72%
C: -0.41%
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
global positive growth market
Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-26 (Crawled : 12:20) - biospace.com/
SNYNF | News | $94.0 -0.27% 0
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
AHPA 4 | $6.125 -9.26% 4.33%
|
|
| O: -5.1%
H: 1.72%
C: -8.48%
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
LGND | $69.92 -1.52% 4.9K
|
Health Technology
|
| O: 0.48%
H: 2.13%
C: -0.81%
treatment fda approval
BIOCORP and NOVO NORDISK Strengthen Their Partnership With a New Agreement on Mallya® Smart Sensor BIOCORP announces the signature of a partnership agreement with Novo Nordisk for the commercialization...
Published: 2022-10-26 (Crawled : 07:00) - biospace.com/
SNYNF | News | $94.0 -0.27% 0
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
PCVX | $58.99 -2.17% 110K
|
Health Technology
|
| O: 2.12%
H: 18.76%
C: 14.61%
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
mallya partnership sensor smart agreement
Dassault Systèmes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future “EVolutive Facilities”
Published: 2022-10-26 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% 0
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
transfer sanofi
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
ACON | $0.49 70.14% 24M
|
n/a
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.13 56.5% 500K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.